- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 498/06 - Peri-condensed systems
Patent holdings for IPC class C07D 498/06
Total number of patents in this class: 317
10-year publication summary
|
29
|
17
|
25
|
13
|
17
|
12
|
16
|
17
|
24
|
13
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4855 |
20 |
| Incyte Holdings Corporation | 667 |
14 |
| Merck Patent GmbH | 5768 |
11 |
| Samsung Display Co., Ltd. | 35269 |
7 |
| LG Chem, Ltd. | 17656 |
7 |
| Incyte Corporation | 1024 |
7 |
| Genentech, Inc. | 4001 |
5 |
| Janssen Pharmaceutica N.V. | 3362 |
5 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 708 |
5 |
| KYORIN Pharmaceutical Co., Ltd. | 167 |
5 |
| Adlai Nortye Biopharma Co., Ltd. | 57 |
5 |
| Glaxosmithkline Intellectual Property Development Limited | 765 |
4 |
| Henkel AG & Co. KGaA | 10611 |
4 |
| CTI Biopharma Corp. | 33 |
4 |
| Rigel Pharmaceuticals, Inc. | 538 |
4 |
| Onkure, Inc. | 26 |
4 |
| Jubilant Epipad LLC | 10 |
4 |
| AstraZeneca AB | 2895 |
3 |
| AstraZeneca UK Limited | 628 |
3 |
| Canon Inc. | 40398 |
3 |
| Other owners | 193 |